4 ms·
It sounds to me like the modern process is just working up GMO yeast matabolites. I feel like the main issue is probably going to be patents and not something t
by usrn 4y ago
It sounds to me like the modern process is just working up GMO yeast matabolites. I feel like the main issue is probably going to be patents and not something technical.
- colinmhayes 4y agoCan’t you use older recipes?
- usrn 4y agoMy understanding is that the older stuff is actually cheap, it's just much harder to manage and that's what people don't like.
- idealmedtech 4y agoMost older expired IP insulin just isn't very convenient to use for most people; it requires more intense participation from the people using it, so you tend to get worse results (imagine if you had to actively think about breathing in enough oxygen every single waking hour of your life -- it's exhausting). The longer acting, more specialized insulins are still heavily patented. When insulin takes longer to work, the person using it has to think less about the insulin and actually gets to live their life rather than think about blood sugar all day. Now, if you closed the loop and used older insulins, you'd have good control and less issues since a computer would bear the cognitive load, but glucose control, especially in the outpatient setting, is ridiculously hard. If you think you can solve it though, give it a shot. It's a multi billion dollar market and a lot of lives you can improve.
- gpm 4y agoDo state governments have to respect patents? Edit: Answering myself here, they do not: https://www.vorys.com/publications-2574.html https://www.vorys.com/publications-2574.html
- HWR_14 4y agoYes, state governments have to respect patents. So does the federal government. However, many patents that are issued in association with a research grant include a clause that allows the government to use the patent without charge. I have no idea if any/many insulin patents are included in such clauses.
- deleted 4y ago[deleted]